Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016)

Clinical trial NCT05289271 · COMPLETED

Trial details

NCT number: NCT05289271
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccines, Combined Hexavalent Vaccine

Start date: 2022-03-25
Primary completion: 2022-08-30
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.